Skip Navigation

Advertise|Press|Contact|FAQ|About Us


Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, FL

Clinical Trial Details


Research Study Summary

A 22-week research study is evaluating if a new investigational insulin can provide effective and consistent blood sugar control in people with type 2 diabetes.


You may qualify if you:

  • Are 18 years of age or older
  • Have taken insulin for at least 12 weeks
  • Have had a diagnosis of type 2 diabetes for at least 24 weeks
  • Have taken an unchanged dose of Oral Antidiabetic Drugs (OAD) for at least 12 weeks
  • Have an HbA1c level between 7.0-10.0%
  • Have a BMI of 45 kg/m2 or less

Contact us for more

To Learn more

Both Male and Female


18 and up

Overall Status



22 Weeks

Facility Type



Rochelle Dobson
Metabolic Research Institute, Inc.
1515 N. Flagler Dr., Ste 440
West Palm Beach, FL 33401
Phone: 561-802-3060
Fax: 561-802-3260

View Map

Research Center Information: Metabolic Research Institute, Inc.

CW ID: 176682

Date Last Changed: July 22, 2013

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.